| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:P110 fragment
CAS:1411976-18-5
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
| Company Name: |
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
|
| Tel: |
0571-87213919 17306812703 |
| Email: |
3007955328@qq.com |
| Products Intro: |
Product Name:P110 fragment
CAS:1411976-18-5
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
|
| Product Name: | P110 | | Synonyms: | L-Serine, L-α-aspartyl-L-leucyl-L-leucyl-L-prolyl-L-arginylglycyl-;P110 fragment;P110;P110 heptapeptide | | CAS: | 1411976-18-5 | | MF: | C32H56N10O11 | | MW: | 756.85 | | EINECS: | | | Product Categories: | | | Mol File: | 1411976-18-5.mol |  |
| density | 1.47±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 3.01±0.10(predicted) | | form | Solid | | color | White to off-white | | Sequence | Asp-Leu-Leu-Pro-Arg-Gly-Ser |
| Uses | P110 heptapeptide, a peptide inhibitor of Drp1-Fis1 interaction, reduces pathology in numerous models of neurodegeneration, ischemia, and sepsis without blocking the physiological functions of Drp1[1]. | | References | [1] Luis Rios, et al. Targeting an allosteric site in dynamin-related protein 1 to inhibit Fis1-mediated mitochondrial dysfunction. Nat Commun. 2023 Jul 19;14(1):4356. DOI:10.1038/s41467-023-40043-0 |
| | P110 Preparation Products And Raw materials |
|